Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19

Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19

Administering N-acetylcysteine (NAC) could counteract the effect of free radicals, improving the clinical evolution of patients admitted to the Intensive Care Unit (ICU). This study aimed to investigate the clinical and biochemical effects of administering NAC to critically ill patients with COVID-1...

Full description

Bibliographic Details
Main Authors: Yenifer Gamarra-Morales, Lourdes Herrera-Quintana, Jorge Molina-López, Héctor Vázquez-Lorente, Juan Francisco Machado-Casas, José Castaño-Pérez, José Miguel Pérez-Villares, Elena Planells
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Nutrients
Subjects:
COVID-19
N-acetylcysteine
mortality
antioxidant
pneumonia
biomarker
Online Access:https://www.mdpi.com/2072-6643/15/9/2235

Internet

https://www.mdpi.com/2072-6643/15/9/2235

Similar Items